OptimizeRx

OptimizeRx News

News

0

Ticker

OPRX

ISIN

US68401U2042

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

OptimizeRx Stock News

OptimizeRx is being monitored by journalists and investors worldwide. We gather the latest OptimizeRx news here.

OptimizeRx Stock Press Releases

OptimizeRx regularly publishes news on the company's website that are relevant for investors.

OptimizeRx News 2026

This page contains all current news, analysis and press releases for OptimizeRx stock (OPRX, ISIN: US68401U2042). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at OptimizeRx.

OptimizeRx Stock

OptimizeRx The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation.